⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL260879 | 0.81 | — | — | |
| SCHEMBL146975 | 0.74 | — | — | |
| SCHEMBL1401619 | 0.70 | — | — | |
| SCHEMBL2353732 | 0.70 | — | — | |
| SCHEMBL1116593 | 0.67 | — | — | |
| SCHEMBL2347540 | 0.65 | — | — | |
| SCHEMBL145305 | 0.65 | — | — | |
| SCHEMBL17514579 | 0.62 | — | — | |
| SCHEMBL1531580 | 0.58 | — | — | |
| SCHEMBL30074493 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101679411-B | MAPK/ERK kinase inhibitors | TAKEDA PHARMACEUTICAL | 2013-04-17 | — | — | CN | claimed |
| CN-101679411-B | MAPK/ERK kinase inhibitors | TAKEDA PHARMACEUTICAL | 2013-04-17 | — | — | CN | disclosed |
| EP-1372653-B1 | ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS | MERCK & CO INC (US) | 2006-10-04 | — | — | EP | disclosed |
| US-7015235-B2 | Acylated piperidine derivatives as melanocortin-4 receptor agonists | MERCK & CO., INC. (US) | 2006-03-21 | — | — | US | disclosed |
| US-20060035935-A1 | Acylated piperidine derivatives as melanocortin-4 receptor agonists | GOULET MARK T | 2006-02-16 | — | — | US | disclosed |